Drug companies have lost a tool to stop unauthorized imports of lower cost versions of their drugs from other countries after a U.S. Supreme Court ruling limiting patent rights after a sale, but lawyers say that there are still ways to stop the flow of foreign-market drugs. Drug companies sometimes charge much lower prices in other countries, and use various means, such as patent laws, to prevent third parties from importing and selling those drugs in the U.S.
展开▼
